Terumo Corporation

Founded Akasenkenkōki Co., Ltd. by Dr. Shibasaburo Kitahara and other physicians, aiming to domesticate high-quality thermometers.

Decided the name and launched the 'Jintan Thermometer'.

Decided the name and launched the 'Jintan Thermometer'.

Renamed to Jintan Thermometer Co., Ltd.

Launched Japan's first disposable syringe, entering the disposable medical device field.

To enhance medical safety, launched Japan's first disposable injection syringe, entering the disposable medical device field.

Launched Japan's first disposable syringe, entering the disposable injection syringe field.

Released Japan's first disposable injection needle.

Introduced Japan's first blood bag, supporting the country's blood business.

Introduced Japan's first blood bag, supporting the country's blood business.

Established Terumo Medical Co., Ltd.

Established Terumo Europe Co., Ltd. in Belgium.

Established Terumo Europe Co., Ltd.

Based on technology accumulated from blood bag development, launched Japan's first infusion solution in a soft bag.

Changed company name from Jintan Terumo Co., Ltd. to the current Terumo Corporation.

Released a hollow-fiber artificial kidney (dialyzer), entering the artificial organ field.

Launched Japan's first high-calorie infusion base solution in a soft bag.

Launched Japan's first high-calorie infusion base solution in a soft bag.

Introduced the world's first porous hollow-fiber artificial lung.

Introduced the world's first porous hollow-fiber artificial lung.

Through a public offering of 12 million shares at an offering price of 1,220 yen, increased capital to 2.6 billion yen and listed shares on the Second Section of the Tokyo Stock Exchange.

Through a public offering of 12 million shares at an offering price of 1,220 yen, increased capital to 2.6 billion yen and listed shares on the Second Section of the Tokyo Stock Exchange.

Released Japan's first hospital-grade electronic thermometer.

Released a predictive electronic thermometer for hospitals.

Discontinued production of flat mercury thermometers in consideration of the environment.

Discontinued production of flat mercury thermometers in consideration of the environment (the packaging process ended on March 20, 1985).

Reclassified our shares to the First Section of the Tokyo Stock Exchange.

Launched a catheter system for angiography, entering the intravascular catheter diagnosis and treatment field.

Released a peritoneal dialysis system, entering the home medical care field.

Opened the R&D facility 'Shonan Center'.

Launched a blood glucose monitoring system, entering the diabetes field.

Established 'Taiermao Medical Products (Hangzhou) Co., Ltd.' in Hangzhou, Zhejiang Province, China.

Established a joint venture with Changchun Kangda Medical Instruments Co., Ltd. in Changchun, China, to manufacture, develop, and sell blood bags.

Established a joint venture 'Terumo Penpol Co., Ltd.' with Penpol Co., Ltd. in India as the second overseas blood bag production site.

Acquired the artificial heart-lung business from 3M in the United States and established Terumo Cardiovascular Systems Co., Ltd.

Released prefilled syringes (drug-filled injectors).

Commenced operations of Terumo Philippines Co., Ltd.

Launched a closed infusion system.

Signed agreements to acquire the home oxygen business from Sumitomo Bakelite Co., Ltd. and to acquire 93% of the shares of MIKI KEN Co., Ltd., a manufacturer and distributor of concentrated oxygen equipment.

Established Terumo Medical Care Co., Ltd., acquiring Sumitomo Bakelite's operations, and commenced business on November 1.

Signed agreements to acquire the home oxygen business from Sumitomo Bakelite and to acquire shares of a concentrated oxygen equipment manufacturer, establishing Terumo Medical Care Co., Ltd., and commenced business.

Transferred the dialyzer business to Asahi Medical Co., Ltd.

Transferred the dialyzer business to Asahi Medical Co., Ltd.

Constructed Terumo Medical Planex as a facility dedicated to the creation and dissemination of medical technology.

Constructed Terumo Medical Planex.

British Vascular Tech Ltd., a manufacturer and distributor of artificial blood vessels, joined the Terumo Group.

Released the world's first high-calorie infusion solution with multivitamin supplementation.

Launched the world's thinnest insulin and other injection needles.

Microvention Inc., a U.S. manufacturer and distributor of intracranial treatment devices, joined the Terumo Group and launched coils for intracranial embolization.

Acquired the artificial heart valve business from Germany's Kora GmbH.

Established Olympus Terumo Biomaterials Co., Ltd.

Opened the Terumo Vietnam factory in Hanoi.

Released an implanted left ventricular assist device in Europe.

Released drug-eluting coronary stents in Europe.

Acquired the shares of Clinical Supply Co., Ltd., a manufacturer and distributor in the catheter-based oncology (interventional oncology) field, and established Terumo Clinical Supply Co., Ltd.

Acquired the shares of Clinical Supply Co., Ltd., a manufacturer and distributor in the catheter-based oncology field, and established Terumo Clinical Supply Co., Ltd.

Established Terumo Americas Holdings Inc.

Global blood and cell technology company, Calidian BCT Inc. (now Terumo BCT), joined the Terumo Group.

Strengthened cell therapy; Terumo BCT Co., Ltd. further reinforced its cell therapy division as a 'Blood and Cell Technology Company'.

Released an implanted left ventricular assist device in Japan.

Global blood and cell technology company, Calidian BCT Inc., joined the Terumo Group.

Acquired Harvest Technologies Inc. in the United States.

Established Terumo Yamaguchi Co., Ltd.

Expanded business in the Chinese market and applied to establish the holding company Terumo (China) Investment Co., Ltd.

Terumo Americas Holdings Inc. acquired all shares of Onset Medical Corporation (California, USA) and obtained large-diameter sheath technology used in cardiovascular catheter therapy.

Terumo Americas Holdings Inc. acquired all shares of Onset Medical Corporation and obtained large-diameter sheath technology used in cardiovascular catheter therapy.

Established the holding company Terumo Asia Holdings Ltd. in Singapore.

Opened the Austria branch.

Joined the UN Global Compact.

Launched infusion bags with a non-venting mechanism.

Released an infusion delivery system that can integrate with in-hospital IT.

Released Frozen Elephant Trunk in Europe.

Established a joint venture with Weigao Co., Ltd. in China for peritoneal dialysis.

Established a joint venture with Weigao Co., Ltd. for peritoneal dialysis.

Terumo BCT Co., Ltd. (Colorado, USA) built a blood product manufacturing plant near Ho Chi Minh City, Vietnam, and held a completion ceremony locally.

Terumo BCT Co., Ltd. built a blood product manufacturing plant in Vietnam and held a completion ceremony.

Established the local sales subsidiary Terumo Rosia Co., Ltd. and commenced operations.

Established the local sales subsidiary Terumo Rosia Co., Ltd. and commenced operations.

Established the local sales subsidiary Terumo India Private Ltd. in India to expand operations.

Released a series of measurement instruments with communication functions.

Established the local sales subsidiary Terumo India Private Ltd. in India.

Established Terumo Medical Innovation, Inc.

Released, in 2016, the world's first regenerative medicine product for severe heart failure: a human (autologous) skeletal muscle-derived cell sheet.

Added the world's first pouch embolization device to the cerebral aneurysm treatment lineup.

Bolton Medical Inc. joined the Terumo Group.

Acquired portions of the catheter-related businesses of Centurion Medical Inc. and Abbott Laboratories.

Bolton Medical Inc., a manufacturer and distributor of stent grafts, joined the Terumo Group.

Released Japan's first patch insulin pump.

Announced a new business brand, 'Terumo Aortic'.

Acquired China Essence Technology Beijing Co., Ltd., a manufacturer and distributor of cardiovascular catheter products.

Revamped the corporate philosophy system, introduced core values shared by employees alongside the immutable corporate philosophy, and revised the Terumo Group Code of Conduct.

Released a filling and finishing system, strengthening the cell therapy field.

Terumo BCT Co., Ltd. further strengthened its cell therapy division as a 'Blood and Cell Technology Company'.

Terumo BCT Co., Ltd. further strengthened its cell therapy division as a 'Blood and Cell Technology Company'.

Terumo BCT Co., Ltd. further strengthened its cell therapy division as a 'Blood and Cell Technology Company'.

Celebrated its 100th anniversary.

Released a raw plasma collection system in the United States.

Announced a new company brand, 'Terumo Medical Care Solutions'.

Established Terumo South Africa Ltd.

Selected for the Ministry of Health, Labour and Welfare's 'FY2026 International Promotion Project for Medical Technologies'.

Advanced the catheter therapy training model developed in Kenya and expanded it to East Africa.